Megen C Wittling

8PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 06, 2026
TLR9 Agonists Potentiate Adoptive T Cell Therapy in Cancer through a B Cell-CD2 Costimulatory Axis.

|Dec 05, 2025
T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy.

Megen C Wittling, Amalia M Rivera-Reyes, Megan M Wyatt

|Aug 25, 2025
Constructing the cure: engineering the next wave of antibody and cellular immune therapies.

Stefanie R Bailey, Eric Bartee, Kyle G Daniels

|Feb 11, 2025
CD4 T cell depletion increases memory differentiation of endogenous and CAR T cells and enhances the efficacy of Super2 and IL-33-armored CAR T cells against solid tumors.

Asmaa O Mohamed, David Tyler Boone, Shannon L Ferry

|Aug 29, 2024
Strategies for Improving CAR T Cell Persistence in Solid Tumors.

Megen C Wittling, Anna C Cole, Brianna Brammer

|Jun 30, 2024
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells.

Megen C Wittling, Hannah M Knochelmann, Megan M Wyatt

Pageof 2

Frequent Collaborators

5 joint publications

Anna C Cole

5 joint publications

Gregory B Lesinski

5 joint publications

Chrystal M Paulos

3 joint publications

Hannah M Knochelmann